chr19-39308241-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000248668.5(LRFN1):c.1708G>A(p.Val570Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,612,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000248668.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRFN1 | NM_020862.2 | c.1708G>A | p.Val570Ile | missense_variant | 5/5 | ENST00000248668.5 | NP_065913.1 | |
LRFN1 | XM_017027033.2 | c.1708G>A | p.Val570Ile | missense_variant | 5/5 | XP_016882522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRFN1 | ENST00000248668.5 | c.1708G>A | p.Val570Ile | missense_variant | 5/5 | 1 | NM_020862.2 | ENSP00000248668.4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000206 AC: 5AN: 242416Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 132954
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459928Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726218
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The c.1708G>A (p.V570I) alteration is located in exon 2 (coding exon 2) of the LRFN1 gene. This alteration results from a G to A substitution at nucleotide position 1708, causing the valine (V) at amino acid position 570 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at